Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by AntibeTribe on Feb 09, 2021 10:57am

Derisking

This is the best partnership move they've made (is legendary deal guy behind this???) because of the double digit royalty secured and agreed re the $20m upfront payment just de-risked a future raise significantly.
Comment by themagicbox on Feb 09, 2021 11:00am
Expect more deals coming now that this one with China is done. Uplist would help so much right now. 
Comment by Doccole on Feb 09, 2021 11:04am
We will have dilution with AH/ATE, but with a Nasdq uplist it could be strategic. im betting GUD and Ate -LATAM is a done deal 
Comment by skibum45 on Feb 09, 2021 11:33am
LATAM partnering with GUD certainly possible... Would be fantastic. At this point I'm looking forward to getting the AH/ATE amalgamation behind us. How this is handled and justified will speak volumes about how management values ATE shareholders. There will be significant dilution for sure, but how much? I'll give the benefit of the doubt to Dan and team. Uplisting, more partnerships ...more  
Comment by RjM2018 on Feb 09, 2021 11:20am
I'd be curious to see the structure of regulatory/milestone payments. In other deals I've seen payments upon start of phase 3 trial... if this is there case here, there could be enough to fund the trial + AH/ATE amalgamation without dilution...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities